[go: up one dir, main page]

ATE550354T1 - Humane ringspezifische bnp-antikörper - Google Patents

Humane ringspezifische bnp-antikörper

Info

Publication number
ATE550354T1
ATE550354T1 AT06734524T AT06734524T ATE550354T1 AT E550354 T1 ATE550354 T1 AT E550354T1 AT 06734524 T AT06734524 T AT 06734524T AT 06734524 T AT06734524 T AT 06734524T AT E550354 T1 ATE550354 T1 AT E550354T1
Authority
AT
Austria
Prior art keywords
antibodies
human ring
bnp antibodies
specific
specific bnp
Prior art date
Application number
AT06734524T
Other languages
English (en)
Inventor
Jessie Shih
Joan Tyner
Matthew Matias
Mary Pinkus
Susan Brophy
David Daghfal
David Hawksworth
Bryan Tieman
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE550354T1 publication Critical patent/ATE550354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06734524T 2005-02-17 2006-02-08 Humane ringspezifische bnp-antikörper ATE550354T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65382905P 2005-02-17 2005-02-17
US11/135,040 US7731965B2 (en) 2005-02-17 2005-05-23 Human ring specific BNP antibodies
PCT/US2006/004318 WO2006088700A2 (en) 2005-02-17 2006-02-08 Human ring specific bnp antibodies

Publications (1)

Publication Number Publication Date
ATE550354T1 true ATE550354T1 (de) 2012-04-15

Family

ID=36716625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06734524T ATE550354T1 (de) 2005-02-17 2006-02-08 Humane ringspezifische bnp-antikörper

Country Status (7)

Country Link
US (1) US7731965B2 (de)
EP (1) EP1853629B1 (de)
JP (1) JP5159324B2 (de)
AT (1) ATE550354T1 (de)
CA (1) CA2598253C (de)
ES (1) ES2383818T3 (de)
WO (1) WO2006088700A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731965B2 (en) 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
JP5364378B2 (ja) * 2005-11-09 2013-12-11 アボット・ラボラトリーズ ヒトｂｎｐ免疫特異的抗体
US20080064045A1 (en) * 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
EP2295445A1 (de) * 2006-09-08 2011-03-16 Mayo Foundation for Medical Education and Research Aquaretische und natriuretische Polypeptide ohne Gefäßerweiterungsaktivität
CA2667012A1 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
WO2008137991A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
WO2010012509A1 (en) 2008-08-01 2010-02-04 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
WO2010012834A1 (en) * 2008-08-01 2010-02-04 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
FR2919611B1 (fr) * 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope
PL2222697T3 (pl) * 2007-11-01 2013-05-31 Astellas Pharma Inc Immunosupresyjne polipeptydy i kwasy nukleinowe
JP5795256B2 (ja) * 2009-07-31 2015-10-14 バイオ−ラッド・イノベーションズＢｉｏ−Ｒａｄ Ｉｎｎｏｖａｔｉｏｎｓ 卒中のインビトロ診断のための方法
KR20140059249A (ko) 2011-08-30 2014-05-15 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 나트륨이뇨 폴리펩티드
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
JPWO2016194855A1 (ja) * 2015-05-29 2018-06-07 株式会社 イギス 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料
WO2020141157A1 (en) * 2018-12-31 2020-07-09 Hytest Ltd Methods and biomarkers for predicting efficacy and evaluation of treatment with drugs modulating neprilysin activity.
WO2023190560A1 (ja) * 2022-03-31 2023-10-05 デンカ株式会社 ヒトｂ型ナトリウム利尿ペプチド又はその前駆体若しくは分解物を検出するための方法、組成物、及びキット

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4634665A (en) 1980-02-25 1987-01-06 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US5179017A (en) 1980-02-25 1993-01-12 The Trustees Of Columbia University In The City Of New York Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4510245A (en) 1982-11-18 1985-04-09 Chiron Corporation Adenovirus promoter system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
AU572173B2 (en) 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
DE3750503T2 (de) 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
CA1339210C (en) 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
DE3905441C2 (de) 1989-02-22 1994-01-20 Minnesota Mining & Mfg Metallische innere Umhüllung für eine elektrische Kabelverbindung
US20020086843A1 (en) 1989-03-01 2002-07-04 Daiichi Pure Chemicals Co., Ltd. Physiologically active polypeptide and DNA
JP2676114B2 (ja) 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
JP2665850B2 (ja) 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
US6090382A (en) 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
CA2248140C (en) 1996-03-04 2005-02-01 Ronald P. Mischak Assay and reagents for quantifying hbnp
CN1161609C (zh) * 1997-09-11 2004-08-11 盐野义制药株式会社 哺乳类γ－BNP衍生物特异的免疫测定方法及其试剂盒
CA2306751C (en) 1997-10-24 2006-12-12 Shionogi & Co., Ltd. Method for inhibiting degradation of natriuretic peptides and improved method for measuring natgriuretic peptides with the use of the same
US6117644A (en) 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
DE19847690A1 (de) 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
JP3297392B2 (ja) 1999-01-28 2002-07-02 沖電気工業株式会社 半導体記憶装置
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20030199000A1 (en) 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
US7396913B2 (en) 2002-10-14 2008-07-08 Abbott Laboratories Erythropoietin receptor binding antibodies
US8263325B2 (en) 2002-11-15 2012-09-11 Ottawa Heart Institute Research Corporation Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis
WO2004082639A2 (en) 2003-03-19 2004-09-30 Baylor College Of Medicine Detecting coronary artery disease with bnp during stress testing
US7341838B2 (en) 2003-04-17 2008-03-11 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US7445933B2 (en) 2003-07-16 2008-11-04 Abbott Laboratories, Inc. Stable calibrators or controls for measuring human natriuretic peptides
AU2005299355A1 (en) 2004-10-27 2006-05-04 Medimmune, Llc Modulation of antibody specificity by tailoring the affinity to cognate antigens
US7731965B2 (en) 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies

Also Published As

Publication number Publication date
US7731965B2 (en) 2010-06-08
CA2598253C (en) 2013-08-06
CA2598253A1 (en) 2006-08-24
US20060183154A1 (en) 2006-08-17
WO2006088700A2 (en) 2006-08-24
JP5159324B2 (ja) 2013-03-06
EP1853629B1 (de) 2012-03-21
ES2383818T3 (es) 2012-06-26
EP1853629A2 (de) 2007-11-14
WO2006088700A3 (en) 2006-11-02
JP2008530207A (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
HK1253391A1 (zh) 與161p2f10b蛋白結合的抗體和相關分子
AR078650A1 (es) Anticuerpo de union a il-1 beta
EA201390146A1 (ru) Антитела к матриксной металлопротеиназе 9
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
ES2639026T3 (es) Anticuerpos totalmente humanos específicos para CADM1
DK1742966T3 (da) Antistoffer og molekyler afledt deraf som binder til STEAP-1 proteiner
WO2007035633A3 (en) Screening assays and methods
DK1844074T3 (da) Humane antistoffer og proteiner
NO344992B1 (no) Anti-GM-CSF antistoffer og anvendelser for disse
EP1868647A4 (de) Ov064-bindende antikörper und verfahren zu ihrer verwendung
CL2012003245A1 (es) Proteína de unión a antígeno aislada que se une a linfopoyetina estromal tímica (tslp); composición que comprende una proteína de unión a antígeno que une tslp correspondiente a un anticuerpo humano anti-tslp.
SMAP200800060A (it) Anticorpi che legano la proteina umana tirosina fosfatasi beta (hptpbeta) e loro usi
CR20120210A (es) Proteínas de enlace al antigeno il-23 humanas
RS53752B1 (en) ANTITELO PROTIV ILT7
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
NO20080692L (no) SP35 antistoffer og anvendelse derav
DK2185574T3 (da) Antistoffer og relaterede molekyler, der bindes til 24P4C12-proteiner
BR112012009846B8 (pt) método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
IL179332A0 (en) Antibodies and related molecules that bind to psca proteins
MX2009005103A (es) Conjugado anti-idiotipo y su uso como un estandar en un inmunoensayo.
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
ATE465179T1 (de) Antikörper, antikörperfragmente und scfv die an posttranslational modifizierte neurotrophine binden
ZA200709303B (en) Antibodies and related molecules that bind to 161P2F210B proteins